Use of ProteinChip technology for identifying biomarkers of parasitic diseases: The example of porcine cysticercosis (Taenia solium)

Experimental Parasitology

Volumn 120, Issue 4, 2008, Pages 320-329

  Deckers, N ^a,b   Dorny, P ^a,b   Kanobana, K ^a   Vercruysse, J ^b   Gonzalez, A E ^c   Ward, B ^d   Ndao, M ^d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

3 (3 cholamidopropyl)dimethylammonio 1 propanesulfonate; Apo A I; Apo A IV; apolipoprotein A I; apolipoprotein A IV; Biological markers; Cestode; CHAPS; coefficient of variation; CV; Cysticercosis; dithiothreitol; DTT; EDM; expression difference mapping; HDL; high density lipoprotein; IEF; IgG; IMAC; immobilized metal affinity capture; immunoglobulin G; isoelectric focusing; LCAT; lecithin cholesterol acyltransferase; m z; mass to charge ratio; molecular weight; MW; Pig; QC; quality control; S N; SDS; SELDI TOF MS; signal to noise ratio; sodium dodecyl sulfate; Surface Enhanced Laser Desorption Ionization Time of Flight (SELDI TOF); surface enhanced laser desorption ionization time of flight mass spectrometry; Taenia solium; WCX; weak cation exchange

Indexed keywords

APOLIPOPROTEIN A1; CLUSTERIN; HAPTOGLOBIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VITRONECTIN;

ARTICLE; CONTROLLED STUDY; CYSTICERCOSIS; DISEASE CLASSIFICATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SWINE; TAENIA SOLIUM;

ANIMALS; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; CLUSTERIN; CYSTICERCOSIS; FEMALE; HAPTOGLOBINS; MALE; PERU; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROTEIN ARRAY ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SWINE; SWINE DISEASES; TAENIA SOLIUM; TANDEM MASS SPECTROMETRY; VITRONECTIN; ZAMBIA;

CESTODA; SUIDAE; SUS; TAENIA SOLIUM;

EID: 55249104477     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.08.013     Document Type: Article

References (52)

1. Adam B.L., Qu Y., Davis J.W., Ward M.D., Clements M.A., Cazares L.H., Semmes O.J., Schellhammer P.F., Yasui Y., Feng Z., and Wright Jr. G.L. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Research 62 (2002) 3609-3614
2. Au J.S., Cho W.C., Yip T.T., Yip C., Zhu H., Leung W.W., Tsui P.Y., Kwok D.L., Kwan S.S., Cheng W.W., Tzang L.C., Yang M., and Law S.C. Deep proteome profiling of sera from never-smoked lung cancer patients. Biomedicine and Pharmacotherapy 61 (2007) 570-577
3. Baggerly K.A., Edmonson S.R., Morris J.S., and Coombes K.R. High-resolution serum proteomic patterns for ovarian cancer detection. Endocrine-related Cancer 11 (2004) 583-584
4. Baggerly K.A., Morris J.S., and Coombes K.R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20 (2004) 777-785
5. Berge V., Johnson E., and Høgåsen K. Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads. Acta Pathologica, Microbiologica et Immunologica Scandinavica 105 (1997) 17-24
6. Carpintero R., Pineiro M., Andres M., Iturralde M., Alava M.A., Heegaard P.M., Jobert J.L., Madec F., and Lampreave F. The concentration of apolipoprotein A-I decreases during experimentally induced acute-phase processes in pigs. Infection and Immunity 73 (2005) 3184-3187
7. Chen H.H., Lin J.H., Fung H.P., Ho L.L., Yang P.C., Lee W.C., Lee Y.P., and Chu R.M. Serum acute phase proteins and swine health status. Canadian Journal of Veterinary Research 67 (2003) 283-290
8. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Artheriosclerosis, Thrombosis and Vascular Biology 15 (1995) 1987-1994
9. Cockerill G.W., Huehns T.Y., Weerasinghe A., Stocker C., Lerch P.G., Miller N.E., and Haskard D.O. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 103 (2001) 108-112
10. Coombes K.R., Fritsche Jr. H.A., Clarke C., Chen J.N., Baggerly K.A., Morris J.S., Xiao L.C., Hung M.C., and Kuerer H.M. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clinical Chemistry 49 (2003) 1615-1623
11. Coombes K.R., Morris J.S., Hu J., Edmonson S.R., and Baggerly K.A. Serum proteomics profiling-a young technology begins to mature. Nature Biotechnology 23 (2005) 291-292
12. Coombes K.R., Tsavachidis S., Morris J.S., Baggerly K.A., Hung M.C., and Kuerer H.M. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform. Proteomics 5 (2005) 4107-4117
13. Correa D., and Medina-Escutia E. Host-parasite immune relationship in Taenia solium taeniosis and cysticercosis. In: Garcia H.H., and Martinez S.M. (Eds). Taenia solium Taeniasis/Cysticercosis (1999), Editorial Universo, Lima 15-24
14. Deckers N., Kanobana K., Silva M., Gonzalez A.E., Garcia H.H., Gilman R., and Dorny P. Serological responses in porcine cysticercosis: a link with the parasitological outcome of infection. International Journal for Parasitology 38 (2008) 1191-1198
15. Del Brutto O.H. Neurocysticercosis. Seminars in Neurology 25 (2005) 243-251
16. Desrosiers R.R., Beaulieu E., Buchanan M., and Béliveau R. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins. Cell Biochemistry and Biophysics 49 (2007) 182-195
17. Diamandis E.P. Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?. Clinical Chemistry 49 (2003) 1272-1275
18. Diamandis E.P. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. Journal of the National Cancer Institute 96 (2004) 353-356
19. Diamandis E.P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool. Opportunities and potential limitations. Molecular and Cellular Proteomics 3 (2004) 367-378
20. Dorny P., Phiri I.K., Vercruysse J., Gabriel S., Willingham III A.L., Brandt J., Victor B., Speybroeck N., and Berkvens D. A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. International Journal for Parasitology 34 (2004) 569-576
21. Engwegen J.Y., Helgason H.H., Cats A., Harris N., Bonfrer J.M., Schellens J.H., and Beijnen J.H. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World Journal of Gastroenterology 12 (2006) 1536-1544
22. Evans C., Garcia H.H., Gilman R.H., and Friedland J.S. Controversies in the management of cysticercosis. Emerging Infectious Diseases 3 (1997) 403-405
23. Flisser A., Correa D., and Evans C. Taenia solium cysticercosis: new and revisited immunological aspects. In: Singh G., and Prabhakar S. (Eds). Taenia solium cysticercosis; from basic to clinical science (2002), CAB International, Wallingford 15-43
24. Garcia H.H., Evans C.A., Nash T.E., Takayanagui O.M., White A.C., Botero D., Rajshekhar V., Tsang V.C., Schantz P.M., Allan J.C., Flisser A., Correa D., Sarti E., Friedland J.S., Martinez S.M., Gonzalez A.E., Gilman R.H., and Del Brutto O.H. Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Reviews 15 (2002) 747-756
25. Hill S.A., and McQueen M.J. Reverse cholesterol transport-a review of the process and its clinical implications. Clinical Biochemistry 30 (1997) 517-525
26. Hu J., Coombes K.R., Morris J.S., and Baggerly K.A. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Briefings in Functional Genomics and Proteomics 3 (2005) 322-331
27. Johnson E., Berge V., and Høgåsen K. Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization. Scandinavian Journal of Immunology 39 (1994) 281-285
28. Laclette J.P., Shoemaker C.B., Richter D., Arcos L., Pante N., Cohen C., Bing D., and Nicholson-Weller A. Paramyosin inhibits complement C1. Journal of Immunology 148 (1992) 124-128
29. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
30. Lee K.B., Jeon J.H., Choi I., Kwon O.Y., Yu K., and You K.H. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability. Biochemical and Biophysical Research Communications 366 (2008) 905-909
31. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., and Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clinical Chemistry 48 (2002) 1296-1304
32. Liu W., Guan M., Wu D., Zhang Y., Wu Z., Xu M., and Lu Y. Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients. European Urology 47 (2005) 456-462
33. Maizels R.M., and Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nature Reviews Immunology 3 (2003) 733-743
34. Malyarenko D.I., Cooke W.E., Adam B.L., Malik G., Chen H., Tracy E.R., Trosset M.W., Sasinowski M., Semmes O.J., and Manos D.M. Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques. Clinical Chemistry 51 (2005) 65-74
35. Merchant M., and Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21 (2000) 1164-1167
36. Milis L., Morris C.A., Sheehan M.C., Charlesworth J.A., and Pussell B.A. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Clinical and Experimental Immunology 92 (1993) 114-119
37. Morra R., Munteanu M., Bedossa P., Dargere D., Janneau J.L., Paradis V., Ratziu V., Charlotte F., Thibault V., Imbert-Bismut F., and Poynard T. Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics 26 (2007) 847-858
38. Morris J.S., Coombes K.R., Koomen J., Baggerly K.A., and Kobayashi R. Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics 21 (2005) 1764-1775
39. Papadopoulos M.C., Abel P.M., Agranoff D., Stich A., Tarelli E., Bell B.A., Planche T., Loosemore A., Saadoun S., Wilkins P., and Krishna S. A novel and accurate diagnostic test for human African trypanosomiasis. The Lancet 363 (2004) 1358-1363
40. Parra M.D., Fuentes P., Tecles F., Martínez-Subiela S., Martínez J.S., Muñoz A., and Cerón J.J. Porcine acute phase protein concentrations in different diseases in field conditions. Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health 53 (2006) 488-493
41. Petricoin E.F., and Liotta L.A. The vision for a new diagnostic paradigm. Clinical Chemistry 49 (2003) 1276-1278
42. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., and Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 359 (2002) 572-577
43. Petricoin E.F., Ornstein D.K., Paweletz C.P., Ardekani A.M., Hackett P.S., Hitt B.A., Velassco A., Trucco C., Wiegand L., Wood K., Simone C.B., Levine P.J., Linehan W.M., Emmert-Buck M.R., Steinberg S.M., Kohn E.C., and Liotta L.A. Serum proteomic patterns for detection of prostate cancer. Journal of the National Cancer Institute 94 (2002) 1576-1578
44. Qu Y., Adam B.L., Thornquist M., Potter J.D., Thompson M.L., Yasui Y., Davis J., Schellhammer P.F., Cazares L., Clements M., Wright Jr. G.L., and Feng Z. Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. Biometrics 59 (2003) 143-151
45. Qu Y., Adam B.L., Yasui Y., Ward M.D., Cazares L.H., Schellhammer P.F., Feng Z., Semmes O.J., and Wright Jr. G.L. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clinical Chemistry 48 (2002) 1835-1843
46. Rioux M.C., Carmona C., Acosta D., Ward B., Ndao M., Gibbs B.F., Bennett H.P., and Spithill T.W. Discovery and validation of serum biomarkers expressed over the first twelve weeks of Fasciola hepatica infection in sheep. International Journal for Parasitology 38 (2007) 123-136
47. Skytt A., Thysell E., Stattin P., Stenman U.H., Antti H., and Wikstrom P. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. International Journal of Cancer 121 (2007) 615-620
48. Sorace, J.M., Zhan, M., 2003. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics, doi: 10.1186/1471-2105-4-24. Available from: .
49. Terrazas L.I., Bojalil R., Govezensky T., and Larralde C. Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). Journal of Parasitology 84 (1998) 74-81
50. Xiao Z., Prieto D., Conrads T.P., Veenstra T.D., and Issaq H.J. Proteomic patterns: their potential for disease diagnosis. Molecular and Cellular Endocrinology 230 (2005) 95-106
51. Yasui Y., McLerran D., Adam B.L., Winget M., Thornquist M., and Feng Z. An automated peak identification/calibration procedure for high-dimensional protein measures from mass spectrometers. Journal of Biomedicine and Biotechnology 2003 (2003) 242-248
52. Yasui Y., Pepe M., Thompson M.L., Adam B.L., Wright Jr. G.L., Qu Y., Potter J.D., Winget M., Thornquist M., and Feng Z. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics 4 (2003) 449-463